| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
|
MELLIN GW, 1962, NEW ENGL J MED, V267, P1184 MELLIN GW, 1962, NEW ENGL J MED, V267, P1238 LENZ W, 1961, DEUT MED WOCHENSCHR, V86, P2555 LENZ W, 1962, DEUT MED WOCHENSCHR, V87, P1232 KUNZ W, 1956, ARZNEIMITTEL-FORSCH, V6, P426 SHESKIN J, 1965, LEPROSY REV, V36, P183 WIEDEMANN HR, 1961, MED WELT, V37, P1863 BECKMANN R, 1962, ARZNEIMITTEL-FORSCH, V12, P1095 |
Nodes: 2685,
Authors: 6203,
Journals: 662,
Outer References: 16023,
Words: 3995
Collection span: 1956 - 2004
View: Overview. Sorted by LCS.
Page 4: 1 2 3 4 5 6 7 8 9
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 901 | 4 | 9 | 1607 2000 ACTA DERMATO-VENEREOLOGICA 80(1):24-25 Daly BM; Shuster S Antipruritic action of thalidomide | 3 | 9 |
| 902 | 7 | 23 | 1705 2000 DIABETES CARE 23(8):1172-1176 Iqbal N; Zayed M; Boden G Thalidomide impairs insulin action on glucose uptake and glycogen synthesis in patients with type 2 diabetes | 3 | 3 |
| 903 | 10 | 34 | 1711 2000 EUROPEAN JOURNAL OF PHARMACOLOGY 391(1-2):97-103 Ribeiro RA; Vale ML; Ferreira SH; Cunha FQ Analgesic effect of thalidomide on inflammatory pain | 3 | 16 |
| 904 | 1 | 1 | 1737 2000 JOURNAL OF CHILD NEUROLOGY 15(12):838-838 Schoeman JF Thalidomide therapy in childhood tuberculous meningitis | 3 | 4 |
| 905 | 14 | 41 | 1738 2000 JOURNAL OF CHROMATOGRAPHY A 876(1-2):157-167 Meyring M; Chankvetadze B; Blaschke G Simultaneous separation and enantioseparation of thalidomide and its hydroxylated metabolites using high-performance liquid chromatography in common-size columns, capillary liquid chromatography and nonaqueous capillary electrochromatography | 3 | 31 |
| 906 | 9 | 15 | 1745 2000 JOURNAL OF INFECTIOUS DISEASES 181(5):1813-1816 Juffermans NP; Verbon A; Olszyna DP; van Deventer SJH; Speelman P; van der Poll T Thalidomide suppresses up-regulation of human immunodeficiency virus coreceptors CXCR4 and CCR5 on CD4(+) T cells in humans | 3 | 5 |
| 907 | 9 | 16 | 1756 2000 LIFE SCIENCES 66(2):133-141 Thiel R; Kastner U; Neubert R Expression of adhesion receptors on rat limb bud cells and results of treatment with a thalidomide derivative | 3 | 4 |
| 908 | 1 | 1 | 1767 2000 NEW ENGLAND JOURNAL OF MEDICINE 342(13):975-975 Kishi Y; Oki Y; Machida U Thalidomide in multiple myeloma | 3 | 5 |
| 909 | 4 | 18 | 1795 2000 TETRAHEDRON LETTERS 41(14):2275-2278 Luzzio FA; Mayorov AV; Figg WD Thalidomide metabolites. Part 1: Derivatives of (+)-2-(N-phthalimido)-gamma-hydroxyglutamic acid | 3 | 7 |
| 910 | 35 | 44 | 1804 2001 AMERICAN JOURNAL OF THE MEDICAL SCIENCES 321(5):321-326 Moraes M; Russo G Thalidomide and its dermatologic uses | 3 | 9 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 911 | 3 | 5 | 1814 2001 ARCHIVES OF INTERNAL MEDICINE 161(20):2502-2503 Rajkumar SV; Fonseca R; Witzig TE Complete resolution of reflex sympathetic dystrophy with thalidomide treatment | 3 | 4 |
| 912 | 14 | 32 | 1826 2001 BIOORGANIC & MEDICINAL CHEMISTRY 9(4):1059-1065 Gutschow M; Hecker T; Thiele A; Hauschildt S; Eger K Aza analogues of thalidomide: Synthesis and evaluation as inhibitors of tumor necrosis factor-alpha production in vitro | 3 | 8 |
| 913 | 10 | 38 | 1881 2001 BONE MARROW TRANSPLANTATION 28(12):1145-1150 Biagi JJ; Mileshkin L; Grigg AP; Westerman DW; Prince HM Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation | 3 | 5 |
| 914 | 8 | 38 | 1895 2001 BRITISH JOURNAL OF PHARMACOLOGY 133(8):1414-1423 Lienenluke B; Stojanovic T; Fiebig T; Fayyazi A; Germann T; Hecker M Thalidomide impairment of trinitrobenzene sulphonic acid-induced colitis in the rat-role of endothelial cell-leukocyte interaction | 3 | 4 |
| 915 | 6 | 6 | 1930 2001 GASTROENTEROLOGY 120(6):1567-1568 Fox MR; Harris A Intractable insomnia after cessation of treatment with thalidomide | 3 | 3 |
| 916 | 5 | 20 | 1942 2001 HAUTARZT 52:962-965 Hoch O; Muller S; Buttner G; Mensing H Thalidomide in the treatment of cutaneous and systemic sarcoidosis | 3 | 5 |
| 917 | 10 | 27 | 1957 2001 JOURNAL OF CLINICAL IMMUNOLOGY 21(5):357-364 Prehn JL; Landers C; Muller GW; Man HW; Stirling DI; Targan SR Potent inhibition of cytokine production from intestinal lamina propria T cells by phosphodiesterase-4 inhibitory thalidomide analogues | 3 | 3 |
| 918 | 22 | 32 | 1960 2001 JOURNAL OF CLINICAL PHARMACOLOGY 41(6):662-667 Teo SK; Scheffler MR; Kook KA; Tracewell WG; Colburn WA; Stirling DI; Thomas SD Thalidomide dose proportionality assessment following single doses to healthy subjects | 3 | 4 |
| 919 | 10 | 15 | 1965 2001 JOURNAL OF INFECTIOUS DISEASES 184(9):1192-1196 Hanekom WA; Hughes J; Haslett PAJ; Apolles P; Ganiso V; Allin R; Goddard E; Hussey GD; Kaplan G The immunomodulatory effects of thalidomide on human immunodeficiency virus-infected children | 3 | 3 |
| 920 | 0 | 5 | 1973 2001 LANCET ONCOLOGY 2(10):634-635 Hwu WJ; Raizer J; Panageas KS; Lis E Treatment of metastatic melanoma in the brain with temozolomide and thalidomide | 3 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 921 | 12 | 27 | 2026 2002 AMERICAN JOURNAL OF MEDICINE 113(7):603-606 Bennett CL; Schumock GT; Desai AA; Kwaan HC; Raisch DW; Newlin R; Stadler W Thalidomide-associated deep vein thrombosis and pulmonary embolism | 3 | 6 |
| 922 | 4 | 6 | 2032 2002 ANNALS OF ONCOLOGY 13(10):1636-1640 Grover JK; Uppal G; Raina V The adverse effects of thalidomide in relapsed and refractory patients of multiple myeloma | 3 | 4 |
| 923 | 9 | 36 | 2035 2002 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 46(6):1887-1895 Tsenova L; Mangaliso B; Muller G; Chen Y; Freedman VH; Stirling D; Kaplan G Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis | 3 | 5 |
| 924 | 8 | 14 | 2038 2002 ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH 47(3):249-254 Huang F; Gu JR; Zhao W; Zhu J; Zhang JL; Yu DTY One-year open-label trial of thalidomide in ankylosing spondylitis | 3 | 9 |
| 925 | 15 | 82 | 2045 2002 BIOMEDICINE & PHARMACOTHERAPY 56(1):20-30 Zorat F; Pozzato G Thalidomide in myelodysplastic syndromes | 3 | 3 |
| 926 | 34 | 59 | 2126 2002 BLOOD REVIEWS 16(4):207-215 Strasser K; Ludwig H Thalidomide treatment in multiple myeloma | 3 | 4 |
| 927 | 0 | 0 | 2131 2002 BRITISH JOURNAL OF CANCER 86:S26-S26 Marriott JB; Clarke IA; Dredge K; Pandha H; Kristaleit H; Polychronis A; Muller GW; Stirling D; Dalgleish AG Thalidomide analogue CDC-501 is safe and well tolerated by patients with end stage cancer and shows evidence of clinical responses and extensive immune activation | 3 | 3 |
| 928 | 13 | 38 | 2192 2002 GASTROENTEROLOGY 123(1):291-300 Enomoto N; Takei Y; Hirose M; Ikejima K; Miwa H; Kitamura T; Sato N Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production | 3 | 12 |
| 929 | 18 | 23 | 2195 2002 HAEMATOLOGICA 87(3):233-234 Tosi P; Cavo M Thalidomide in multiple myeloma: state of art | 3 | 4 |
| 930 | 4 | 7 | 2196 2002 HAEMATOLOGICA 87(3):327-328 Corso A; Lorenzi A; Orlandi E; Astori C; Mangiacavalli S; Lazzarino M Advantages of using thalidomide for the management of patients with refractory myeloma | 3 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 931 | 14 | 28 | 2212 2002 JAPANESE JOURNAL OF CANCER RESEARCH 93(9):1029-1036 Kakimoto T; Hattori Y; Okamoto S; Sato N; Kamata T; Yamaguchi M; Morita K; Yamada T; Takayama N; Uchida H; Shimada N; Tanigawara Y; Ikeda Y Thalidomide for the treatment of refractory multiple myeloma: Association of plasma concentrations of thalidomide and angiogenic growth factors with clinical outcome | 3 | 3 |
| 932 | 18 | 24 | 2216 2002 JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 767(1):145-151 Teo SK; Chandula RS; Harden JL; Stirling DI; Thomas SD Sensitive and rapid method for the determination of thalidomide in human plasma and semen using solid-phase extraction and liquid chromatography-tandem mass spectrometry | 3 | 4 |
| 933 | 10 | 15 | 2217 2002 JOURNAL OF CLINICAL GASTROENTEROLOGY 35(2):149-150 Kane S; Stone LJ; Ehrenpreis E Thalidomide as "salvage" therapy for patients with delayed hypersensitivity response to infliximab - A case series | 3 | 5 |
| 934 | 5 | 23 | 2258 2002 LEUKEMIA & LYMPHOMA 43(6):1267-1271 Badros A; Morris C; Zangari M; Barlogie B; Tricot G Thalidomide paradoxical effect on concomitant multiple myeloma and myelodysplasia | 3 | 3 |
| 935 | 18 | 38 | 2262 2002 LUPUS 11(2):67-70 Piette JC; Sbai A; Frances C Warning: thalidomide-related thrombotic risk potentially concerns patients with lupus | 3 | 5 |
| 936 | 3 | 21 | 2280 2002 PHARMACEUTICAL RESEARCH 19(4):434-439 Goosen C; Laing TJ; du Plessis J; Goosen TC; Lu GW; Flynn GL Percutaneous delivery of thalidomide and its N-alkyl analogs | 3 | 4 |
| 937 | 14 | 18 | 2281 2002 PHARMACEUTICAL RESEARCH 19(8):1232-1235 Goosen C; Laing TJ; du Plessis J; Goosen TC; Rao TB; Flynn GL Chemical stabilities and biological activities of thalidomide and its N-alkyl analogs | 3 | 3 |
| 938 | 9 | 11 | 2286 2002 REVUE DE MEDECINE INTERNE 23(8):724-727 Gachon J; Grob JJ; Richard MA Thalidomide treatment leading thrombotic events: two cases | 3 | 4 |
| 939 | 8 | 20 | 2407 2003 BRITISH JOURNAL OF CANCER 88(6):822-827 Drake MJ; Robson W; Mehta P; Schofield I; Neal DE; Leung HY An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer | 3 | 9 |
| 940 | 5 | 12 | 2413 2003 BRITISH JOURNAL OF HAEMATOLOGY 121(1):101-103 Steurer M; Sudmeier I; Stauder R; Gastl G Thromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin-alpha | 3 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 941 | 21 | 31 | 2429 2003 CANCER RESEARCH 63(12):3189-3194 Ng SSW; Gutschow M; Weiss M; Hauschildt S; Teubert U; Hecker TK; Luzzio FA; Kruger EA; Eger K; Figg WD Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues | 3 | 5 |
| 942 | 44 | 59 | 2445 2003 CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT 6(1):92-99 Meierhofer C; Wiedermann CJ New insights into the pharmacological and toxicological effects of thalidomide | 3 | 3 |
| 943 | 9 | 39 | 2496 2003 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 305(3):1222-1232 Schafer PH; Gandhi AK; Loveland MA; Chen RS; Man HW; Schnetkamp PPM; Wolbring G; Govinda S; Corral LG; Payvandi F; Muller GW; Stirling DI Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs | 3 | 4 |
| 944 | 13 | 23 | 2497 2003 JOURNAL OF PHARMACY AND PHARMACOLOGY 55(12):1701-1706 Eriksson T; Hoglund P; Turesson I; Waage A; Don BR; Vu J; Scheffler M; Kaysen GA Pharmacokinetics of thalidomide in patients with impaired renal function and while on and off dialysis | 3 | 3 |
| 945 | 10 | 14 | 2499 2003 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 48(4):548-552 Hall VC; El-Azhary RA; Bouwhuis S; Rajkumar SV Dermatologic side effects of thalidomide in patients with multiple myeloma | 3 | 4 |
| 946 | 4 | 7 | 2538 2003 NEUROLOGY 60(5):877-878 Giannini F; Volpi N; Rossi S; Passero S; Fimiani M; Cerase A Thalidomide-induced neuropathy: a ganglionopathy? | 3 | 3 |
| 947 | 15 | 21 | 2547 2003 PHARMACOTHERAPY 23(3):315-318 Horne MK; Figg WD; Arlen P; Gulley J; Parker C; Lakhani N; Parnes H; Dahut WL Increased frequency of venous thromboembolism with the combination of docetaxel and thalidomide in patients with metastatic androgen-independent prostate cancer | 3 | 4 |
| 948 | 7 | 29 | 2560 2003 SEMINARS IN ONCOLOGY 30(2):270-274 Coleman M; Leonard J; Lyons L; Szelenyi H; Niesvizky R Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone | 3 | 5 |
| 949 | 0 | 0 | 2 1959 BRITISH MEDICAL JOURNAL 2(OCT3):635-635 DESOUZA LP THALIDOMIDE | 2 | 3 |
| 950 | 0 | 0 | 8 1960 FEDERATION PROCEEDINGS 19(1):264-264 KUHN WL; VANMAANEN EF EFFECTS OF THALIDOMIDE ON CENTRAL NERVOUS SYSTEM DRUGS | 2 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 951 | 0 | 0 | 16 1961 BRITISH MEDICAL JOURNAL 1(522):829-& SHAFAR J IS THALIDOMIDE TO BLAME | 2 | 3 |
| 952 | 0 | 0 | 22 1961 BRITISH MEDICAL JOURNAL 2(525):1025-& CHEVENS LCF NEUROPATHY AFTER THALIDOMIDE | 2 | 3 |
| 953 | 0 | 0 | 28 1961 BRITISH MEDICAL JOURNAL 2(526):1223-& CAHILL PK NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 2 | 4 |
| 954 | 0 | 0 | 29 1961 BRITISH MEDICAL JOURNAL 2(526):1286-& JEWESBURY ECO; GREENHALGH RN; SIMPSON JA; BURLEY D; RUDD TN NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 2 | 2 |
| 955 | 0 | 0 | 30 1961 BRITISH MEDICAL JOURNAL 2(526):1359-& MAGRATH D NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 2 | 2 |
| 956 | 0 | 0 | 31 1961 BRITISH MEDICAL JOURNAL 2(526):1359-& BROWN JA NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 2 | 2 |
| 957 | 0 | 0 | 34 1961 BRITISH MEDICAL JOURNAL 2(526):1498-& KREMER M; FULLERTON PM NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 2 | 3 |
| 958 | 0 | 0 | 35 1961 BRITISH MEDICAL JOURNAL 2(526):1498-& PIRRIE I NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 2 | 2 |
| 959 | 0 | 0 | 76 1962 BRITISH MEDICAL JOURNAL (5309):920-& WOOLLAM DHM THALIDOMIDE AND MOUSE | 2 | 2 |
| 960 | 0 | 0 | 87 1962 CANADIAN MEDICAL ASSOCIATION JOURNAL 86(14):665-& MUNN JD THALIDOMIDE AND CONGENITAL MALFORMATIONS | 2 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 961 | 1 | 3 | 96 1962 COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES 255(14):1646-& GIROUD A; MERCIERPAROT L; TUCHMANNDUPLESSIS H EMBRYOLOGIE TERATOLOGIQUE - PRODUCTION DE MALFORMATIONS CONGENITALES CHEZ LA SOURIS APRES ADMINISTRATION DE FAIBLES DOSES DE THALIDOMIDE | 2 | 13 |
| 962 | 0 | 0 | 105 1962 JOURNAL OF LABORATORY AND CLINICAL MEDICINE 60(5):875-& FRANK O; ZEFFER H; LEEVY CM; BAKER H METABOLIC LESIONS INDUCED BY THALIDOMIDE | 2 | 3 |
| 963 | 1 | 1 | 129 1962 LANCET 1(7244):1402-& QUIBELL EP THALIDOMIDE-DAMAGED INFANTS | 2 | 2 |
| 964 | 0 | 0 | 135 1962 LANCET 2(7249):249-& DALDERUP LM THALIDOMIDE AND TEETH | 2 | 2 |
| 965 | 0 | 0 | 140 1962 LANCET 2(7251):349-& WIGGLESWORTH R THALIDOMIDE-DAMAGED INFANTS | 2 | 2 |
| 966 | 0 | 1 | 151 1962 LANCET 2(7262):937-& CAMERON JM; CHRISTIE GA THALIDOMIDE AND CONGENITAL ABNORMALITIES | 2 | 6 |
| 967 | 6 | 9 | 157 1962 LIFE SCIENCES (7):333-336 SMITH RL; WILLIAMS RAD; WILLIAMS RT PHTHALOYLISOGLUTAMINE, A METABOLITE OF THALIDOMIDE | 2 | 3 |
| 968 | 5 | 14 | 171 1962 PEDIATRICS 30(4):654-& TAUSSIG HB THALIDOMIDE AND PHOCOMELIA | 2 | 12 |
| 969 | 2 | 4 | 214 1963 COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES 257(1):273-& SALZGEBER B; SALAUN J TERATOLOGIE EXPERIMENTALE - ACTION TERATOGENE DE LA THALIDOMIDE SUR LEMBRYON DE POULET, A DIFFERENTS STADES DU DEVELOPPEMENT | 2 | 5 |
| 970 | 0 | 4 | 225 1963 LANCET 1(727):174-& PETERSEN CE; WIEDEMANN HR THALIDOMIDE AND FOETAL ABNORMALITIES | 2 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 971 | 5 | 20 | 238 1963 LANCET 1(729):1095-& SMITHELLS RW; LECK I INCIDENCE OF LIMB AND EAR DEFECTS SINCE WITHDRAWAL OF THALIDOMIDE | 2 | 24 |
| 972 | 1 | 3 | 246 1963 MEDICINA EXPERIMENTALIS 8(2):66-& GIURGEA C; MOEYERSOONS F ACTION OF THALIDOMIDE ON EEG OF CONSCIOUS, UNRESTRAINED RABBIT | 2 | 8 |
| 973 | 0 | 0 | 252 1963 POULTRY SCIENCE 42(5):1257-& BOONE MA; HAMMOND M; BARNETT BD EFFECT OF THALIDOMIDE ON DOMESTIC FOWL | 2 | 0 |
| 974 | 0 | 1 | 265 1964 ANALYTICA CHIMICA ACTA 30(3):313-& HETMAN JS POLAROGRAPHIC DETERMINATION OF N-PHTHALYLGLUTAMIC ACID IMIDE ( THALIDOMIDE ) | 2 | 6 |
| 975 | 3 | 8 | 266 1964 ANALYTICAL BIOCHEMISTRY 8(1):129-& SANDBERG DH; TURNER DA; BOCK SA QUANTITATIVE MEASUREMENT OF THALIDOMIDE BY GAS-LIQUID CHROMATOGRAPHY | 2 | 4 |
| 976 | 0 | 0 | 267 1964 ANATOMICAL RECORD 148(2):313-& MOORE KL; DWORNIK JJ; DALTON RD CONGENITAL DEFECTS PRODUCED IN RAT BY THALIDOMIDE | 2 | 5 |
| 977 | 14 | 21 | 273 1964 BIOCHEMICAL PHARMACOLOGY 13(6):940-& CHAUDHARY KD; LEMONDE A EFFECT OF THALIDOMIDE ON TRIBOLIUM CONFUSUM DUVAL | 2 | 4 |
| 978 | 19 | 58 | 274 1964 BIOCHEMICAL PHARMACOLOGY 13(11):1489-& TOIVANEN A; TOIVANEN P; MANTYJAR.R; MARKKANEN T MICROBIOLOGICALLY DETERMINED PANTOTHENIC ACID + NICOTINIC ACID CONTENT OF CHICK EMBRYOS AFTER TREATMENT WITH THALIDOMIDE + OF RAT FETUSES NEWBORNS + PLACENTAS FROM MOTHERS TREATED WITH THALIDOMIDE | 2 | 4 |
| 979 | 0 | 9 | 280 1964 COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES 158(4):737-& BERTRAND M; FLORIO R; DELATOUR P; MAGAT A SUR LA POTENTIALISATION DES EFFETS EMBRYOTOXIQUES DU THALIDOMIDE CHEZ LA RATTE | 2 | 3 |
| 980 | 0 | 1 | 281 1964 EXPERIENTIA 20(5):283-& OBBINK HJK; DALDERUP LM EFFECTS OF THALIDOMIDE ON SKELETON OF RAT FOETUS | 2 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 981 | 5 | 14 | 295 1964 NATURE 204(496):939-& TATA JR THALIDOMIDE + INDUCED AMPHIBIAN METAMORPHOSIS | 2 | 3 |
| 982 | 7 | 10 | 299 1964 POULTRY SCIENCE 43(6):1420-& KONDRA PA; SELL JL; MCKIRDY JA EFFECT OF THALIDOMIDE ON REPRODUCTION IN HEN | 2 | 4 |
| 983 | 1 | 8 | 374 1966 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 91(24):1132-& LENZ W CAN THALIDOMIDE SUPPRESS IMMUNOLOGICAL REACTIONS | 2 | 2 |
| 984 | 0 | 0 | 379 1966 FEDERATION PROCEEDINGS 25(2P1):353-& SCHUMACHER H; GILLETTE J EMBRYOTOXIC EFFECTS OF THALIDOMIDE | 2 | 3 |
| 985 | 2 | 14 | 394 1966 LANCET 1(7444):981-& VLADUTIU A ANOTHER CHANCE FOR THALIDOMIDE | 2 | 2 |
| 986 | 0 | 3 | 396 1966 LANCET 1(7447):1134-& CANT JS MINOR OCULAR ABNORMALITIES ASSOCIATED WITH THALIDOMIDE | 2 | 4 |
| 987 | 3 | 27 | 416 1967 AMERICAN JOURNAL OF VETERINARY RESEARCH 28(127):1829-& SZABO KT; STEELMAN RL EFFECTS OF THALIDOMIDE TREATMENT OF INBRED FEMALE MICE ON PREGNANCY FETAL DEVELOPMENT AND MORTALITY OF OFFSPRING | 2 | 2 |
| 988 | 0 | 0 | 418 1967 ARZNEIMITTEL-FORSCHUNG 17(5):646-& BUELENS I TREATMENT WITH THALIDOMIDE OF AN ASTROCYTOMA OF SECOND DEGREE (N-PHTHALYGLUTAMIC ACID IMIDE) | 2 | 3 |
| 989 | 0 | 0 | 432 1967 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 9(6):707-& DAVIGNON M; HELLGREN K; JUHLIN IM; ATTERBAC.B DIAGNOSTIC AND HABILITATION PROBLEMS OF THALIDOMIDE-TRAUMATIZED CHILDREN WITH MULTIPLE HANDICAPS | 2 | 2 |
| 990 | 3 | 8 | 452 1968 BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY 49(2):179-& VICKERS TH CARDIOVASCULAR MALFORMATIONS IN RABBIT THALIDOMIDE EMBRYOPATHY | 2 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 991 | 0 | 0 | 496 1970 ARCHIV FUR KLINISCHE UND EXPERIMENTELLE DERMATOLOGIE 237(1):312-& SHESKIN J; SAGHER F CURRENT STATUS OF THALIDOMIDE TREATMENT OF LEPROSY AND LEPRA REACTIONS | 2 | 5 |
| 992 | 3 | 11 | 502 1970 EXPERIENTIA 26(3):305-& MIURA M; WUEST H POTENTIATING EFFECT OF THALIDOMIDE ON METHYLCHOLANTHRENE ONCOGENESIS IN MICE | 2 | 5 |
| 993 | 0 | 0 | 509 1970 NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE 266(4-5):408-& NEUBERT D; KOHLER E HYPOTHETICAL EXPLANATION OF EMBRYTOXIC ACTION OF THALIDOMIDE | 2 | 3 |
| 994 | 3 | 11 | 515 1971 ARZNEIMITTEL-FORSCHUNG 21(12):2022-& KOCH H; STOCKING.L TERATOLOGY STUDY ON 3-(1,4-ENDOXO-CYCLOHEXANE-2-EXO-3-EXO-DICARBOXIMIDO)-PIPERIDINE-2,6-DIONE (K-2604), ANOTHER COMPOUND WITH SEDATIVE-HYPNOTIC ACTIVITY AND STRUCTURALLY RELATED TO THALIDOMIDE | 2 | 4 |
| 995 | 0 | 0 | 533 1971 TERATOLOGY 4(2):247-& TANIMURA T; TANAKA O; NISHIMUR.H EFFECTS OF THALIDOMIDE AND QUINE DIHYDROCHLORIDE ON JAPANESE AND RHESUS MONKEY EMBRYOS | 2 | 5 |
| 996 | 11 | 17 | 536 1971 TOXICOLOGY AND APPLIED PHARMACOLOGY 18(1):208-& LEHMANN H; NIGGESCH.A TERATOLOGIC EFFECTS OF THALIDOMIDE IN HIMALAYAN RABBITS | 2 | 11 |
| 997 | 6 | 10 | 557 1972 PHARMAZIE 27(6):418-& MEISE W SYNTHESIS AND TERATOLOGICAL TESTING OF SOME THALIDOMIDE METABOLITES | 2 | 4 |
| 998 | 8 | 29 | 610 1975 ARCHIV DER PHARMAZIE 308(11):863-868 PISCHEK G; KOCH H THALIDOMIDE ANALOGS .6. BIOLOGIC HALF-LIFE OF THALIDOMIDE-LIKE COMPOUND K-2004 | 2 | 6 |
| 999 | 1 | 5 | 643 1977 BRITISH MEDICAL JOURNAL 2(6096):1191-1191 MURPHY R; MOHR P 2 CONGENITAL NEUROLOGICAL ABNORMALITIES CAUSED BY THALIDOMIDE | 2 | 2 |
| 1000 | 1 | 2 | 652 1977 LANCET 2(8034):405-405 TEPPO L; SAXEN E; TERVO T; PARTIO E; VONBONSDORFF H; SALMELA J; AVIKAINEN V; ISOMAKI M; KREES R THALIDOMIDE-TYPE MALFORMATIONS AND SUBSEQUENT OSTEOSARCOMA | 2 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1001 | 0 | 0 | 666 1978 FEDERATION PROCEEDINGS 37(3):503-503 GORDON G; BLAKE DA IS THALIDOMIDE A MUTAGENT | 2 | 2 |
| 1002 | 1 | 2 | 675 1978 LANCET 1(8072):1042-1042 SMITHELLS RW THALIDOMIDE, ABSENT APPENDIX, AND SWEATING | 2 | 4 |
| 1003 | 0 | 0 | 705 1979 IRCS MEDICAL SCIENCE-BIOCHEMISTRY 7(9):451-451 STOKES PA; VARDY PH; MCBRIDE WG; LONG MA DISTRIBUTION OF THALIDOMIDE WITHIN EMBRYONIC-TISSUES | 2 | 2 |
| 1004 | 0 | 0 | 711 1979 TERATOLOGY 19(2):A51-A51 THEISEN CT; SPENCER MP MORPHOLOGICAL OBSERVATIONS IN RHESUS-MONKEY EMBRYOS FOLLOWING MATERNAL THALIDOMIDE ADMINISTRATION | 2 | 3 |
| 1005 | 2 | 8 | 713 1979 TERATOLOGY 19(3):341-344 JACKSON AJ; SCHUMACHER HJ TERATOGENIC ACTIVITY OF A THALIDOMIDE ANALOGOUS EM12 IN RATS ON A LOW-ZINC DIET | 2 | 25 |
| 1006 | 4 | 40 | 769 1981 TERATOLOGY 23(3):351-364 NEWMAN LM; HENDRICKX AG FETAL EAR MALFORMATIONS INDUCED BY MATERNAL INGESTION OF THALIDOMIDE IN THE BONNET MONKEY (MACACA, RADIATA) | 2 | 13 |
| 1007 | 5 | 10 | 781 1982 DEVELOPMENT GROWTH & DIFFERENTIATION 24(2):217-222 MCBRIDE WG; STOKES PA; VARDY PH MATERNAL THALIDOMIDE TREATMENT AND CELL-DIVISION IN CULTURED RABBIT EMBRYOS - AUTOMATED IMAGE-ANALYSIS OF AUTORADIOGRAPHS | 2 | 2 |
| 1008 | 6 | 17 | 802 1983 BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH 16(2):105-109 SCHMIDT M; SALZANO FM CLINICAL-STUDIES ON TEENAGE BRAZILIAN VICTIMS OF THALIDOMIDE | 2 | 3 |
| 1009 | 2 | 5 | 810 1983 BRITISH MEDICAL JOURNAL 287(6404):1550-1550 EFTHIMIOU J; SPIRO SG EFFECT OF THALIDOMIDE ON OROGENITAL ULCERATION | 2 | 2 |
| 1010 | 5 | 14 | 822 1983 HAUTARZT 34(4):168-170 SHESKIN J; MUCKTER H; FRANKUS E SUPIDIMIDE, A NON-TERATOGENIC ANALOG OF THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS | 2 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1011 | 1 | 2 | 898 1985 LANCET 1(8427):511-511 JENKINS S; POWELL RJ; ALLEN BR; LITTLEWOOD S; MAURICE PD; SMITH NJ THALIDOMIDE, OROGENITAL ULCERS, AND RISK OF TERATOGENICITY | 2 | 3 |
| 1012 | 8 | 8 | 913 1986 ARTHRITIS AND RHEUMATISM 29(10):1296-1296 SHEEHAN NJ THALIDOMIDE NEUROTOXICITY AND RHEUMATOID-ARTHRITIS | 2 | 2 |
| 1013 | 2 | 10 | 955 1988 ARCHIV DER PHARMAZIE 321(6):371-373 KOCH HP; STEINACKER C IMPROVEMENT OF SOLUBILITY AND STABILITY OF THALIDOMIDE BY INCLUSION COMPLEXATION WITH CYCLODEXTRINS | 2 | 4 |
| 1014 | 5 | 5 | 962 1988 ARTHRITIS AND RHEUMATISM 31(1):145-146 GUTIERREZRODRIGUEZ O; STARUSTABACAL P; GUTIERREZMONTES O THALIDOMIDE-INDUCED NEUROPATHY IN RHEUMATOID-ARTHRITIS PATIENTS | 2 | 4 |
| 1015 | 3 | 17 | 981 1988 TERATOLOGY 38(3):217-219 WARKANY J WHY I DOUBTED THAT THALIDOMIDE WAS THE CAUSE OF THE EPIDEMIC OF LIMB DEFECTS OF 1959 TO 1961 | 2 | 3 |
| 1016 | 3 | 17 | 987 1989 ARCHIV DER PHARMAZIE 322(8):499-505 KNABE J; OMLOR G SYNTHESES OF THE RACEMATES AND THE ENANTIOMERS OF ANALOGS OF THALIDOMIDE ALKYLATED IN 3-POSITION AND DETERMINATION OF THEIR ABSOLUTE-CONFIGURATION | 2 | 4 |
| 1017 | 1 | 6 | 994 1989 GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 13(1):104-104 PATEY O; CHARASZ N; ROUCAYROL AM; MALKIN JE; LAFAIX C THALIDOMIDE AND INTESTINAL INVOLVEMENT IN BEHCETS SYNDROME | 2 | 3 |
| 1018 | 14 | 33 | 1002 1990 ACTA ENDOCRINOLOGICA 123(1):79-83 LUEPRASITSAKUL W; ABEND S; ALEX S; REINHARDT W; APPEL MC; BRAVERMAN LE EFFECT OF THALIDOMIDE ON THE INCIDENCE OF IODINE-INDUCED AND SPONTANEOUS LYMPHOCYTIC THYROIDITIS AND SPONTANEOUS DIABETES-MELLITUS IN THE BB/WOR RAT | 2 | 2 |
| 1019 | 0 | 2 | 1015 1990 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 263(11):1473-1473 RANDALL T RESEARCH FOCUSES ON IMMUNOSUPPRESSIVE EFFECT, UNKNOWN TERATOGENIC MECHANISM OF THALIDOMIDE | 2 | 2 |
| 1020 | 1 | 4 | 1028 1990 PRESSE MEDICALE 19(15):722-722 SAMSON J; KUFFER R; RADEFF B THALIDOMIDE TREATMENT OF CHOICE OF APHTHAE IN HIV-INFECTION | 2 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1021 | 7 | 19 | 1032 1990 TERATOLOGY 41(2):243-244 KOCH HP PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY | 2 | 4 |
| 1022 | 2 | 11 | 1041 1991 BRITISH MEDICAL JOURNAL 303(6814):1404-1405 HOOPER M USE OF THALIDOMIDE IN LEPROSY | 2 | 2 |
| 1023 | 15 | 23 | 1042 1991 CANCER LETTERS 60(2):129-133 GERSHBEIN LL THE THALIDOMIDE ANALOG, EM-12, ENHANCES 1,2-DIMETHYLHYDRAZINE-INDUCTION OF RAT COLON ADENOCARCINOMAS | 2 | 6 |
| 1024 | 2 | 2 | 1072 1992 NEW ENGLAND JOURNAL OF MEDICINE 327(10):735-735 VOGELSANG GB THALIDOMIDE NEUROPATHY - REPLY | 2 | 2 |
| 1025 | 0 | 0 | 1075 1992 TERATOLOGY 46(5):417-418 LENZ W A PERSONAL PERSPECTIVE ON THE THALIDOMIDE TRAGEDY | 2 | 5 |
| 1026 | 0 | 0 | 1079 1992 TROPICAL DOCTOR 22(3):139-140 WATERS MFR THALIDOMIDE PERIPHERAL NEUROPATHY - REPLY | 2 | 4 |
| 1027 | 1 | 3 | 1110 1993 PRESSE MEDICALE 22(1):37-37 PEDAILLES S; TROUSSARD X; LAUNAY V; BAZIN A; SENTIAS C; SURBLED M SCLERODERMATOUS SKIN REACTION IN GRAFT-VERSUS-HOST DISEASE TREATED WITH THALIDOMIDE | 2 | 2 |
| 1028 | 0 | 0 | 1125 1994 BRITISH MEDICAL JOURNAL 308(6931):739-739 CHRISTIE B THALIDOMIDE VICTIMS WIN REVIEW OF COMPENSATION | 2 | 2 |
| 1029 | 1 | 3 | 1130 1994 BRITISH MEDICAL JOURNAL 309(6948):193-194 ASSCHER W SAFETY OF THALIDOMIDE | 2 | 2 |
| 1030 | 4 | 28 | 1177 1995 BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH 28(10):1069-1076 AARESTRUP FM; GONCALVESDACOSTA SC; SARNO EN THE EFFECT OF THALIDOMIDE ON BCG-INDUCED GRANULOMAS IN MICE | 2 | 9 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1031 | 5 | 5 | 1195 1995 GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 19(1):128-129 SIRE S; FRAISSE P; REY D; JACQUEMIN C; KEMPF G; PARTISANI M; LANG JM EFFECTIVENESS OF THALIDOMIDE IN THE TREATMENT OF ESOPHAGEAL ULCERS IN AIDS | 2 | 2 |
| 1032 | 0 | 0 | 1203 1995 JOURNAL OF INVESTIGATIVE DERMATOLOGY 105(3):479-479 CHARUE D; CHAUVIN E; DUGUET C; REVUZ J; BAGOT M THALIDOMIDE DECREASES THE PRODUCTION OF GM-CSF AND TNF-ALPHA IN MIXED EPIDERMAL-CELL LYMPHOCYTE-REACTION | 2 | 2 |
| 1033 | 14 | 24 | 1211 1995 LIFE SCIENCES 58(4):337-348 Nogueira AC; Neubert R; Felies A; JacobMuller U; Frankus E; Neubert D Thalidomide derivatives and the immune system .6. Effects of two derivatives with no obvious teratogenic potency on the pattern of integrins and other surface receptors on blood cells of marmosets | 2 | 3 |
| 1034 | 23 | 39 | 1258 1996 DEVELOPMENT GROWTH & DIFFERENTIATION 38(1):47-57 Audit CO; Eger K; Aimar C Possible involvement of an acylation mechanism in thalidomide-induced teratogenesis of the newt (Pleurodeles waltl) | 2 | 2 |
| 1035 | 2 | 13 | 1271 1996 INTERNATIONAL JOURNAL OF STD & AIDS 7(7):518-520 Lewis DA; Amerasinghe CN; Murphy SM Successful treatment of Behcet's syndrome in an African female patient with thalidomide | 2 | 3 |
| 1036 | 0 | 0 | 1278 1996 JOURNAL OF INVESTIGATIVE DERMATOLOGY 106(4):845-845 Smith C; Friednash M; Nguyen C; Knauf T; Walsh P Failure of thalidomide as an anti-angiogenesis factor in a murine melanoma model | 2 | 3 |
| 1037 | 0 | 0 | 1294 1996 REPRODUCTIVE TOXICOLOGY 10(1):1-2 Robert E Thalidomide and isotretinoin - Why treat them differently? | 2 | 6 |
| 1038 | 0 | 0 | 1308 1997 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 54(20):2270-& Miller JL Thalidomide recommended for approval under tight restrictions | 2 | 2 |
| 1039 | 0 | 0 | 1352 1997 JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 14(4):20-20 Welles L; Little R; Wyvill K; Pluda J; Figg W; Lietzau J; Merced T; Humphrey R; Yarchoan R Preliminary results of a phase II study of oral thalidomide in patients with HIV infection and Kaposi's sarcoma (KS) | 2 | 3 |
| 1040 | 4 | 4 | 1354 1997 JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 15(5):392-392 Sharp M; Getty J; Klausner JD Thalidomide use is associated with weight gain in HIV-1-positive clients | 2 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1041 | 12 | 20 | 1383 1997 ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS 84(4):362-364 Elad S; Galili D; Garfunkel AA; Or R Thalidomide-induced perioral neuropathy | 2 | 3 |
| 1042 | 7 | 10 | 1394 1998 AIDS PATIENT CARE AND STDS 12(12):903-906 Fu CS; Conteas CN; LaRiviere MJ Successful treatment of idiopathic colitis and proctitis using thalidomide in persons infected with human immunodeficiency virus | 2 | 3 |
| 1043 | 0 | 0 | 1401 1998 ARTHRITIS AND RHEUMATISM 41(9):S60-S60 Scoville CD Open trial using methotrexate and thalidomide in the treatment of rheumatoid arthritis. | 2 | 2 |
| 1044 | 2 | 19 | 1465 1998 METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY 20(9):739-742 Guinan P; Shaw M; Mirochnik Y; Slobodskoy L; Ray V; Rubenstein M Paclitaxel is more effective than thalidomide in inhibiting LNCaP tumor growth in a prostate cancer model | 2 | 5 |
| 1045 | 0 | 0 | 1494 1999 ARTHRITIS AND RHEUMATISM 42(9):S373-S373 El Hassani S; Dougados M; Gombert B; Amor B; Breban M Treatment of severe retractory spondylarthopathy (SPA) with thalidomide: Results of an open study. | 2 | 6 |
| 1046 | 4 | 5 | 1527 1999 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 17(3):393-393 de Wazieres B; Gil H; Vuitton DA; Dupond JL Treatment of recurrent oro-genital ulceration with low doses of thalidomide | 2 | 3 |
| 1047 | 13 | 34 | 1537 1999 ELECTROPHORESIS 20(12):2425-2431 Meyring M; Chankvetadze B; Blaschke G Enantioseparation of thalidomide and its hydroxylated metabolites using capillary electrophoresis with various cyclodextrins and their combinations as chiral buffer additives | 2 | 13 |
| 1048 | 0 | 0 | 1539 1999 GASTROENTEROLOGY 116(4):A745-A745 Kane SV; Ehrenpreis ED; Cohen LB; Hanauer SB; Cohen RD Therapeutic efficacy of thalidomide for patients with refractory Crohn's disease (CD) | 2 | 5 |
| 1049 | 0 | 0 | 1540 1999 GASTROENTEROLOGY 116(4):A767-A767 Macumber C; Wettstein AP; Vickers CR; Hing M; Edwards PD; Byrnes DJ; Meagher AP Thalidomide-effective therapy in chronic resistant inflammatory bowel disease. Department of gastroenterology. St. Vincent's Hospital, Sydney, Australia. | 2 | 3 |
| 1050 | 0 | 0 | 1542 1999 GASTROENTEROLOGY 116(4):A843-A843 Wedel S; Bauditz J; Suk A; Lochs H Efficacy of thalidomide in Crohn's disease. | 2 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1051 | 1 | 3 | 1586 1999 NATURE MEDICINE 5(8):853-853 Guenzler V Mechanisms of thalidomide teratogenicity | 2 | 3 |
| 1052 | 7 | 12 | 1611 2000 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 57(17):1607-1610 Eriksson T; Wallin R; Hoglund P; Roth B; Qi ZQ; Ostraat O; Bjorkman S Low bioavailability of rectally administered thalidomide | 2 | 2 |
| 1053 | 11 | 60 | 1614 2000 AMERICAN JOURNAL OF NEURORADIOLOGY 21(5):881-890 Cha S; Knopp EA; Johnson G; Litt A; Glass J; Gruber ML; Lu S; Zagzag D Dynamic contrast-enhanced T2*-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin | 2 | 23 |
| 1054 | 6 | 20 | 1626 2000 ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY 126(1):89-92 Dios PD; Sopena B; Cameselle J; Butron M; Crespo M; Ocampo A Thalidomide for the treatment of acquired immunodeficiency syndrome-associated refractory oral ulcers | 2 | 3 |
| 1055 | 0 | 0 | 1628 2000 ARTHRITIS AND RHEUMATISM 43(9):S396-S396 Huang F; Gu J; Braun J; Sieper J; Yu DT Identifying the targets of thalidomide and anti-TNF alpha antibody treatments in ankylosing spondylitis (AS). | 2 | 5 |
| 1056 | 7 | 20 | 1709 2000 EUROPEAN CYTOKINE NETWORK 11(4):574-579 van Crevel R; Vonk AG; Netea MG; Kullberg BJ; van der Meer JWM Modulation of LPS-, PHA-and M-tuberculosis-mediated cytokine production by pentoxifylline and thalidomide | 2 | 3 |
| 1057 | 102 | 148 | 1764 2000 NATIONAL MEDICAL JOURNAL OF INDIA 13(3):132-141 Grover JK; Vats V; Gopalakrishna R; Ramam M Thalidomide: A re-look | 2 | 3 |
| 1058 | 0 | 0 | 1773 2000 ONCOLOGY-NEW YORK 14(12):9-10 Rajkumar SV Thalidomide in hematologic and oncologic disease - Proceedings of an Investigators' Meeting - May 20, 2000, New Orleans - Introduction | 2 | 2 |
| 1059 | 7 | 18 | 1778 2000 ONCOLOGY-NEW YORK 14(12):33-36 Amato R Thalidomide for recurrent renal-cell cancer in a 40-year-old man | 2 | 2 |
| 1060 | 5 | 14 | 1813 2001 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 45(5):1547-1549 Juffermans NP; Verbon A; Schultz MJ; Hack CE; van Deventer SJH; Speelman P; van der Poll T Thalidomide inhibits granulocyte responses in healthy humans after ex vivo stimulation with bacterial antigens | 2 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1061 | 6 | 6 | 1819 2001 ARTHRITIS AND RHEUMATISM 44(10):2456-2457 Lee L; Lawford R; McNeil HP The efficacy of thalidomide in severe refractory seronegative spondylarthropathy: comment on the letter by Breban et al | 2 | 5 |
| 1062 | 1 | 4 | 1820 2001 ARTHRITIS AND RHEUMATISM 44(10):2457-2458 Breban M; Dougados M The efficacy of thalidomide in severe refractory seronegative spondylarthropathy: Reply | 2 | 5 |
| 1063 | 3 | 23 | 1821 2001 BIOCHEMICAL PHARMACOLOGY 62(8):1081-1086 Onat D; Stahl W; Sies H Stimulation of gap junctional intercellular communication by thalidomide and thalidomide analogs in human fetal skin fibroblasts (HFFF2) and in rat liver epithelial cells (WB-F344) | 2 | 3 |
| 1064 | 17 | 41 | 1827 2001 BIOORGANIC & MEDICINAL CHEMISTRY 9(5):1279-1291 Hess S; Akermann MA; Wnendt S; Zwingerberger K; Eger K Synthesis and immunological activity of water-soluble thalidomide prodrugs | 2 | 4 |
| 1065 | 1 | 3 | 1889 2001 BRITISH JOURNAL OF HAEMATOLOGY 114(1):245-245 Myers B; Grimley C; Dolan G Thalidomide and low-dose dexamethasone in myeloma treatment | 2 | 3 |
| 1066 | 3 | 4 | 1890 2001 BRITISH JOURNAL OF HAEMATOLOGY 115(1):234-234 Myers B; Grimley C; Crouch D; Dolan G Lack of response to thalidomide in plasmacytomas | 2 | 4 |
| 1067 | 8 | 37 | 1897 2001 CANCER CHEMOTHERAPY AND PHARMACOLOGY 47(4):319-326 Zhou S; Paxton JW; Kestell P; Tingle MD; Ching LM In vitro and in vivo kinetic interactions of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid with thalidomide and diclofenac | 2 | 9 |
| 1068 | 11 | 31 | 1898 2001 CANCER CHEMOTHERAPY AND PHARMACOLOGY 47(6):541-544 Zhou SF; Kestell P; Tingle MD; Ching LM; Paxton JW A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomide | 2 | 5 |
| 1069 | 28 | 123 | 1912 2001 CURRENT OPINION IN ONCOLOGY 13(5):374-381 Krown SE Management of Kaposi sarcoma: the role of interferon and thalidomide | 2 | 17 |
| 1070 | 36 | 49 | 1914 2001 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 126(42):1178-1182 Tuinmann G; Hegewisch-Becker S; Hossfeld DK New indications for thalidomide | 2 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1071 | 27 | 28 | 1970 2001 JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION 32(3):322-324 Strauss RS; Das FM Thalidomide-induced sensory neuropathy | 2 | 3 |
| 1072 | 6 | 6 | 1972 2001 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 45(6):965-966 George SJ; Hsu S Lichen planopilaris treated with thalidomide | 2 | 5 |
| 1073 | 6 | 15 | 1994 2001 OPHTHALMOLOGICA 215(1):70-73 Parentin F; Da Pozzo S; Lepore L; Perissutti P Thalidomide effectiveness for bilateral chronic idiopathic anterior uveitis in a three-year-old child | 2 | 2 |
| 1074 | 7 | 40 | 1995 2001 OPHTHALMOLOGICA 215(4):284-289 Kaven C; Spraul CW; Zavazava N; Lang GK; Lang GE Thalidomide and prednisolone inhibit growth factor-induced human retinal pigment epithelium cell proliferation in vitro | 2 | 7 |
| 1075 | 16 | 18 | 2001 2001 REVUE DE MEDECINE INTERNE 22(1):5-7 Grosbois B; Duguet C Thalidomide: the revival | 2 | 4 |
| 1076 | 12 | 25 | 2009 2001 SEMINARS IN ONCOLOGY 28(6):593-596 Desikan RK; Jagannath S Therapeutic dilemmas with thalidomide in multiple myeloma: Case discussions | 2 | 2 |
| 1077 | 3 | 4 | 2012 2001 SWISS MEDICAL WEEKLY 131(9-10):133-133 Trojan A; Anagnostara A; Fost L Thalidomide: near complete regression of extramedullary bulk in refractory multiple myeloma | 2 | 2 |
| 1078 | 4 | 33 | 2050 2002 BIOORGANIC & MEDICINAL CHEMISTRY 10(9):3067-3073 Lima LM; Castro P; Machado AL; Fraga CAM; Lugnier C; de Moraes VLG; Barreiro EJ Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues | 2 | 6 |
| 1079 | 4 | 4 | 2055 2002 BLOOD 99(11):4248-4248 Lee FC Second response to lower-dose thalidomide in a patient with multiple myeloma | 2 | 2 |
| 1080 | 90 | 130 | 2159 2002 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 20(5):709-718 Ossandon A; Cassara EAM; Priori R; Valesini G Thalidomide: focus on its employment in rheumatologic diseases | 2 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1081 | 19 | 30 | 2210 2002 INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE 6(7):569-572 Fu LM; Fu-Liu CS Thalidomide and tuberculosis | 2 | 3 |
| 1082 | 16 | 34 | 2214 2002 JOURNAL OF CARDIAC FAILURE 8(5):306-314 Agoston I; Dibbs ZI; Wang F; Muller G; Zeldis JB; Mann DL; Bozkurt B Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure | 2 | 3 |
| 1083 | 23 | 30 | 2236 2002 JOURNAL OF LEUKOCYTE BIOLOGY 72(5):939-945 Mohty M; Stoppa AM; Blaise D; Isnardon D; Gastaut JA; Olive D; Gaugler A Differential regulation of dendritic cell function by the immunomodulatory drug thalidomide | 2 | 6 |
| 1084 | 15 | 40 | 2243 2002 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 300(3):768-776 Hansen JM; Harris KK; Philbert MA; Harris C Thalidomide modulates nuclear redox status and preferentially depletes glutathione in rabbit limb versus rat limb | 2 | 5 |
| 1085 | 4 | 26 | 2257 2002 LEUKEMIA & LYMPHOMA 43(2):401-406 Dmoszynska A; Bojarska-Junak A; Domanski D; Rolinski J; Hus M; Soroka-Wojtaszko M Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma | 2 | 6 |
| 1086 | 3 | 5 | 2261 2002 LEUKEMIA RESEARCH 26(10):965-966 Tsirigotis P; Venetis E; Rontogianni D; Dervenoulas J; Kontopidou F; Apostolidis P Thalidomide in the treatment of myelodysplastic syndrome with fibrosis | 2 | 2 |
| 1087 | 9 | 9 | 2314 2003 ANNALS OF ONCOLOGY 14(3):501-502 Trojan A; Chasse E; Gay B; Pichert G; Taverna C Severe hepatic toxicity due to thalidomide in relapsed multiple myeloma | 2 | 2 |
| 1088 | 22 | 30 | 2318 2003 ANTI-CANCER DRUGS 14(5):331-335 Dredge K; Dalgleish AG; Marriott JB Thalidomide analogs as emerging anti-cancer drugs | 2 | 6 |
| 1089 | 11 | 30 | 2324 2003 ARCHIVES OF DERMATOLOGY 139(1):50-54 Housman TS; Jorizzo JL; McCarty MA; Grummer SE; Fleischer AB; Sutej PG Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus | 2 | 3 |
| 1090 | 5 | 6 | 2417 2003 BRITISH JOURNAL OF HAEMATOLOGY 122(1):160-161 Harris E; Behrens J; Samson D; Rahemtulla A; Russell NH; Byrne JL Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia | 2 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1091 | 4 | 10 | 2419 2003 BRITISH JOURNAL OF HAEMATOLOGY 123(2):305-308 Thompson MA; Witzig TE; Kumar S; Timm MM; Haug J; Fonseca R; Greipp PR; Lust JA; Rajkumar SV Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma | 2 | 4 |
| 1092 | 9 | 31 | 2431 2003 CHEMICAL & PHARMACEUTICAL BULLETIN 51(9):1098-1102 Suizu M; Muroya Y; Kakuta H; Kagechika H; Tanatani A; Nagasawa K; Hashimoto Y Cyclooxygenase inhibitors derived from thalidomide | 2 | 2 |
| 1093 | 166 | 221 | 2442 2003 CLINICAL THERAPEUTICS 25(2):342-395 Matthews SJ; McCoy C Thalidomide: A review of approved and investigational uses | 2 | 5 |
| 1094 | 21 | 37 | 2449 2003 DRUG METABOLISM AND DISPOSITION 31(4):469-475 Miyata M; Tamura E; Motoki K; Nagata K; Yamazoe Y Thalidomide-induced suppression of embryo fibroblast proliferation requires CYP1A1-mediated activation | 2 | 2 |
| 1095 | 74 | 144 | 2456 2003 EXPERT OPINION ON INVESTIGATIONAL DRUGS 12(7):1211-1225 Fanelli M; Sarmiento R; Gattuso D; Carillio G; Capaccetti B; Vacca A; Roccaro AM; Gasparini G Thalidomide: a new anticancer drug? | 2 | 6 |
| 1096 | 5 | 41 | 2470 2003 INTERNATIONAL JOURNAL OF ONCOLOGY 22(1):165-173 Yata K; Otsuki T; Kurebayashi J; Uno M; Fujii T; Yawata Y; Takata A; Hyodoh F; Sugihara T Expression of angiogenic factors including VEGFs and the effects of hypoxia and thalidomide on human myeloma cells | 2 | 3 |
| 1097 | 7 | 25 | 2480 2003 JOURNAL OF CLINICAL ONCOLOGY 21(14):2732-2739 Lee CK; Barlogie B; Munshi N; Zangari M; Fassas A; Jacobson J; van Rhee F; Cottler-Fox M; Muwalla F; Tricot G DTPACE: An effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma | 2 | 8 |
| 1098 | 16 | 45 | 2491 2003 JOURNAL OF MEDICINAL CHEMISTRY 46(24):5222-5229 Zhu XX; Giordano T; Yu QS; Holloway HW; Perry TA; Lahiri DK; Brossi A; Greig NH Thiothalidomides: Novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity | 2 | 2 |
| 1099 | 8 | 21 | 2505 2003 JOURNAL OF THROMBOSIS AND HAEMOSTASIS 1(3):445-449 Minnema MC; Fijnheer R; De Groot PG; Lokhorst HM Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment | 2 | 2 |
| 1100 | 6 | 25 | 2559 2003 SEMINARS IN ONCOLOGY 30(2):265-269 Dimopoulos MA; Tsatalas C; Zomas A; Hamilos G; Panayiotidis P; Margaritis D; Matsouka C; Economopoulos T; Anagnostopoulos N Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone | 2 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1101 | 0 | 1 | 4 1959 BRITISH MEDICAL JOURNAL 2(OCT31):888-888 NYAZAI AKK THALIDOMIDE | 1 | 2 |
| 1102 | 0 | 3 | 10 1960 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 103(3):580-581 HARRIS SC; ALLGOOD JP ANALGESIA ENHANCING EFFECT OF THALIDOMIDE | 1 | 4 |
| 1103 | 2 | 13 | 11 1961 AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 81(6):1245-& NULSEN RO TRIAL OF THALIDOMIDE IN INSOMNIA ASSOCIATED WITH THIRD TRIMESTER | 1 | 1 |
| 1104 | 3 | 5 | 21 1961 BRITISH MEDICAL JOURNAL 2(525):876-& [Anon] THALIDOMIDE NEUROPATHY | 1 | 0 |
| 1105 | 0 | 0 | 32 1961 BRITISH MEDICAL JOURNAL 2(526):1435-& HAYMAN DJ NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 1 | 2 |
| 1106 | 0 | 0 | 33 1961 BRITISH MEDICAL JOURNAL 2(526):1498-& SWIFT EF NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 1 | 1 |
| 1107 | 0 | 0 | 39 1961 BRITISH MEDICAL JOURNAL 2(526):1644-& GOSLING PH WITHDRAWAL OF THALIDOMIDE (DISTAVAL) | 1 | 1 |
| 1108 | 0 | 0 | 40 1961 BRITISH MEDICAL JOURNAL 2(526):1716-& HAYMAN DJ WITHDRAWAL OF THALIDOMIDE (DISTAVAL) | 1 | 1 |
| 1109 | 5 | 8 | 54 1962 BRITISH JOURNAL OF RADIOLOGY 35(418):687-691 GRAINGER RG; MORRIS AH; WARD P PHOCOMELIC DEFORMITY AND MATERNAL THALIDOMIDE ADMINISTRATION - A REPORT OF 4 CASES | 1 | 2 |
| 1110 | 1 | 1 | 59 1962 BRITISH MEDICAL JOURNAL (5280):792-& MORGAN BC THALIDOMIDE (DISTAVAL) AND FOETAL ABNORMALITIES | 1 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1111 | 0 | 1 | 79 1962 BRITISH MEDICAL JOURNAL (5314):1257-& HEWITT HB THALIDOMIDE AND CANCER | 1 | 1 |
| 1112 | 9 | 13 | 85 1962 CANADIAN MEDICAL ASSOCIATION JOURNAL 86(10):462-& [Anon] THALIDOMIDE AND CONGENITAL MALFORMATIONS | 1 | 0 |
| 1113 | 3 | 6 | 90 1962 CANADIAN MEDICAL ASSOCIATION JOURNAL 87(12):670-& IVES EJ THALIDOMIDE AND ANAL ABNORMALITIES | 1 | 8 |
| 1114 | 0 | 0 | 112 1962 LANCET 1(7219):46-& HAYMAN DJ THALIDOMIDE AND CONGENITAL ABNORMALITIES - REPLY | 1 | 1 |
| 1115 | 6 | 8 | 118 1962 LANCET 1(7224):307-& [Anon] THALIDOMIDE AND CONGENITAL MALFORMATIONS | 1 | 0 |
| 1116 | 0 | 0 | 130 1962 LANCET 2(7245):46-& WHATLEY E THALIDOMIDE-DAMAGED BABIES | 1 | 2 |
| 1117 | 0 | 0 | 143 1962 LANCET 2(7253):452-& TRUETA J; AGERHOLM M THALIDOMIDE-DAMAGED INFANTS | 1 | 1 |
| 1118 | 0 | 0 | 150 1962 LANCET 2(7262):931-& [Anon] CONGENITAL ABNORMALITIES DUE TO THALIDOMIDE | 1 | 0 |
| 1119 | 0 | 0 | 152 1962 LANCET 2(7263):986-& [Anon] CONGENITAL ABNORMALITIES DUE TO THALIDOMIDE | 1 | 0 |
| 1120 | 0 | 0 | 159 1962 MEDICAL JOURNAL OF AUSTRALIA 1(17):649-& VICKERS TH CONGENITAL ABNORMALITIES AND THALIDOMIDE | 1 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1121 | 0 | 0 | 161 1962 MEDICAL JOURNAL OF AUSTRALIA 1(24):949-& LUMER RH CONGENITAL ABNORMALITIES AND THALIDOMIDE | 1 | 1 |
| 1122 | 0 | 0 | 205 1963 CANADIAN MEDICAL ASSOCIATION JOURNAL 88(19):962-& LAZURE D HABILITATION OF PATIENTS WITH CONGENITAL MALFORMATIONS ASSOCIATED WITH THALIDOMIDE - PSYCHIATRIC AND PSYCHOLOGICAL ASPECTS | 1 | 1 |
| 1123 | 0 | 0 | 208 1963 CANADIAN MEDICAL ASSOCIATION JOURNAL 88(19):980-& ARMSTRONG KS HABILITATION OF PATIENTS WITH CONGENITAL MALFORMATIONS ASSOCIATED WITH THALIDOMIDE - MEDICAL-SOCIAL ASPECTS | 1 | 1 |
| 1124 | 1 | 2 | 224 1963 JOURNAL OF ECONOMIC ENTOMOLOGY 56(5):720-& HODGSON E EFFECT OF THALIDOMIDE ON GROWTH AND REPRODUCTION OF PHORMIA REGINA | 1 | 2 |
| 1125 | 0 | 0 | 227 1963 LANCET 1(727):501-& KAJII T; SHINOHARA M THALIDOMIDE IN JAPAN | 1 | 5 |
| 1126 | 1 | 6 | 241 1963 LANCET 2(729):151-& KAJII T; GOTO M CLEFT LIP AND PALATE AFTER THALIDOMIDE | 1 | 2 |
| 1127 | 0 | 7 | 243 1963 LANCET 2(731):889-& KAJII T; AKICHIKA M; DOHMEN S; SHINOHARA M; KIKUCHI K THALIDOMIDE AND UMBILICAL ARTERY | 1 | 11 |
| 1128 | 2 | 2 | 250 1963 NEW ENGLAND JOURNAL OF MEDICINE 268(11):624-& HUSSEY LM; WEINBERG M ACTION OF THALIDOMIDE | 1 | 1 |
| 1129 | 5 | 10 | 251 1963 NEW ENGLAND JOURNAL OF MEDICINE 269(2):92-& TAUSSIG HB EVILS OF CAMOUFLAGE AS ILLUSTRATED BY THALIDOMIDE | 1 | 5 |
| 1130 | 2 | 2 | 254 1963 POULTRY SCIENCE 42(6):1479-& BLOW WL; COOK FW; KARE MR EFFECTS OF THALIDOMIDE ON REPRODUCTION IN CHICKENS | 1 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1131 | 2 | 10 | 283 1964 GANN 55(1):57-& SUGIURA K; WUEST HM EFFECT OF THALIDOMIDE ON TRANSPLANTABLE MOUSE RAT + HAMSTER TUMORS | 1 | 6 |
| 1132 | 6 | 15 | 291 1964 MEDICINA EXPERIMENTALIS 11(2):119-& BERGSTROM RM; BERGSTROM L; PUTKONEN P; SAINIO K EFFECTS OF THALIDOMIDE ON ELECTRICAL ACTIVITY OF BRAIN IN INTRAUTERINE GUINEA-PIG FOETUS | 1 | 3 |
| 1133 | 3 | 7 | 298 1964 POULTRY SCIENCE 43(2):506-& BOONE MA; BARNETT BD; HAMMOND M EFFECT OF THALIDOMIDE ON CHICKENS + EMBRYOS | 1 | 3 |
| 1134 | 0 | 0 | 310 1965 AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH 55(5):703-707 KELSEY FO PROBLEMS RAISED FOR THE FDA BY THE OCCURRENCE OF THALIDOMIDE EMBRYOPATHY IN GERMANY, 1960-1961 | 1 | 3 |
| 1135 | 0 | 1 | 314 1965 BIOCHEMICAL JOURNAL 97(2):P14-& FABRO S; SMITH RL; WILLIAMS RT PERSISTENCE OF MATERNALLY ADMINISTERED [14C] THALIDOMIDE IN RABBIT EMBRYO | 1 | 2 |
| 1136 | 1 | 3 | 321 1965 BRITISH MEDICAL JOURNAL 2(5469):1064-& JAMES WH TERATOGENETIC PROPERTIES OF THALIDOMIDE | 1 | 2 |
| 1137 | 13 | 27 | 351 1965 POULTRY SCIENCE 44(6):1583-& NABER EC; LARGENT EJ THALIDOMIDE TERATOGENESIS IN DEVELOPING CHICK EMBRYO AND ITS RELATIONSHIP TO VITAMIN METABOLISM | 1 | 2 |
| 1138 | 1 | 11 | 360 1966 ACTA PHARMACOLOGICA ET TOXICOLOGICA 24(4):443-& LARSEN V; BREDAHL E EMBRYOTOXIC EFFECT ON RABBITS OF MONOPHENYLBUTAZONE (MONAZAN) COMPARED WITH PHENYLBUTAZONE AND THALIDOMIDE | 1 | 9 |
| 1139 | 7 | 10 | 367 1966 CANADIAN JOURNAL OF MICROBIOLOGY 12(2):333-& JASMIN R; JOHNSON WJ RENVERSEMENT PAR LA THIAMINE ET LE PYRIDOXAL DE LINHIBITION PRODUITE PAR LHYDROXY-3 THALIDOMIDE SUR LA CROISSANCE DESCHERICHIA COLI | 1 | 1 |
| 1140 | 0 | 7 | 377 1966 EXPERIENTIA 22(10):669-& RINALDI L ACTION OF THALIDOMIDE ON ENDOSTEAL OSSIFICATION IN PIGEON | 1 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1141 | 3 | 5 | 389 1966 LANCET 1(7428):92-& BOHM R; NITSCH K ANOTHER CHANCE FOR THALIDOMIDE | 1 | 1 |
| 1142 | 2 | 2 | 393 1966 LANCET 1(7442):882-& MOUZAS GL ANOTHER CHANCE FOR THALIDOMIDE | 1 | 2 |
| 1143 | 2 | 20 | 411 1967 ACTA ANATOMICA 66(2):226-& GIL DR INFLUENCE OF THALIDOMIDE ON DEVELOPMENT OF CHICK EMBRYOS CULTIVATED IN VITRO | 1 | 1 |
| 1144 | 36 | 79 | 413 1967 ACTA VITAMINOLOGICA ET ENZYMOLOGICA 21(4):123-& FABRO S ON MECHANISM OF TERATOGENIC ACTION OF THALIDOMIDE | 1 | 1 |
| 1145 | 6 | 27 | 420 1967 ARZNEIMITTEL-FORSCHUNG 17(11):1360-& GLEISS J GROWTH OF EMBRYOS OF SINAPIS ALBA INHIBITED BY N-PHTHALYGLUTAMIC ACID IMIDE(THALIDOMIDE) . NA-PHENYLETHYLBARBITURIC ACID (PHENOBARBITAL-NA) AND ALPHA-ETHYL-ALPHA-PHENYLGLUTARIMIDE)GLUTETHIMIDE) | 1 | 12 |
| 1146 | 6 | 15 | 426 1967 BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY 48(2):150-& COOK MJ; MOORE DF EFFECT OF THALIDOMIDE ON DEVELOPING RAT FOETUS | 1 | 4 |
| 1147 | 5 | 12 | 434 1967 JOURNAL OF ANIMAL SCIENCE 26(5):1082-& GRAVES CN; SALISBUR.GW; LODGE JR MAMMALIAN SPERMATOZOAN METABOLISM IN PRESENCE OF THALIDOMIDE | 1 | 1 |
| 1148 | 4 | 22 | 450 1968 ARZNEIMITTEL-FORSCHUNG 18(6):661-& BRODE E EXPERIMENTAL STUDIES ON CYCLIC IMIDES .I. INFLUENCE OF THALIDOMIDE ON PITUITARY-ADRENAL AXIS | 1 | 2 |
| 1149 | 2 | 6 | 454 1968 BRITISH MEDICAL JOURNAL 3(5609):42-& BERKELEY JS THALIDOMIDE IN LEPROSY | 1 | 1 |
| 1150 | 5 | 45 | 456 1968 BULLETIN DU CANCER 55(3):413-& BAROCHE C ACTIONS OF THALIDOMIDE ON DROSOPHILA WITH REGARD TO DEVELOPMENT AND TUMORIGENESIS - COMPARISONS WITH EFFECT OF POTASSIUM PHTHALATE AND SOME NON-PHTHALATE COMPOUNDS | 1 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1151 | 0 | 0 | 494 1970 ANATOMICAL RECORD 166(2):306-& GIACONE J; SCHMIDT HL INTERNAL MALFORMATIONS PRODUCED BY THALIDOMIDE AND RELATED COMPOUNDS IN RHESUS MONKEYS | 1 | 2 |
| 1152 | 4 | 10 | 506 1970 JOURNAL OF THE CHEMICAL SOCIETY D-CHEMICAL COMMUNICATIONS (12):778-& ALLEN FH; TROTTER J CRYSTAL AND MOLECULAR STRUCTURE OF THALIDOMIDE | 1 | 0 |
| 1153 | 4 | 15 | 522 1971 EXPERIENTIA 27(6):671-& ECKERT T; DORR NW INTERMOLECULAR INTERACTIONS OF FOLIC ACID WITH N-PHTHALOYL-DL-GLUTAMIC ACID PROBLEM OF TERATOGENIC ACTION OF THALIDOMIDE | 1 | 2 |
| 1154 | 0 | 2 | 529 1971 NEW ENGLAND JOURNAL OF MEDICINE 284(9):481-& CURRAN WJ THALIDOMIDE TRAGEDY IN GERMANY - END OF A HISTORIC MEDICOLEGAL TRIAL | 1 | 4 |
| 1155 | 14 | 26 | 531 1971 TERATOLOGY 4(1):75-& KELLER GR; BLAKE DA COMPARATIVE STUDIES ON ABSORPTION OF H-3 THALIDOMIDE IN RABBITS AND RATS | 1 | 3 |
| 1156 | 0 | 0 | 540 1972 ACTA PAEDIATRICA SCANDINAVICA 61(4):497-& SCHAFER KH SPASTIC HYPERTROPHIC PYLORIC STENOSIS AS EMBRYONAL MALFORMATION CAUSED BY THALIDOMIDE | 1 | 3 |
| 1157 | 2 | 13 | 546 1972 ACTA PHARMACOLOGICA ET TOXICOLOGICA 31(1-2):27-& JONSSON BG EFFECTS OF THALIDOMIDE ON EMBRYONIC-DEVELOPMENT OF AXOLOTL (AMBYSTOMA MEXICANUM) | 1 | 1 |
| 1158 | 10 | 28 | 548 1972 ANNALEN DER CHEMIE-JUSTUS LIEBIG 755(NJAN):51-& KOCH H; KOTLAN J; FARKOUH E; PISCHEK G THALIDOMIDE ANALOGS .4. | 1 | 2 |
| 1159 | 1 | 4 | 552 1972 INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY 10(4):314-& THOMAS BP; VARIA MR; MEMON GN; ANSARI MM EFFECT OF THALIDOMIDE ON LIVER REGENERATION IN RAT | 1 | 1 |
| 1160 | 0 | 9 | 566 1973 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 15(6):719-727 MCFIE J; ROBERTSO.J PSYCHOLOGICAL TEST RESULTS OF CHILDREN WITH THALIDOMIDE DEFORMITIES | 1 | 8 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1161 | 6 | 23 | 588 1973 TOXICOLOGY AND APPLIED PHARMACOLOGY 25(1):77-83 GILANI SH CARDIOVASCULAR MALFORMATIONS IN CHICK-EMBRYO INDUCED BY THALIDOMIDE | 1 | 4 |
| 1162 | 0 | 2 | 589 1973 ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE 111(1):93-103 HUENGES E; IMMICH H; MARQUARD.E; ROMPE G; GRESSMAN.C; MAU H DOCUMENTATION AND REPORT ON THALIDOMIDE DAMAGE | 1 | 3 |
| 1163 | 7 | 19 | 617 1976 ARCHIV DER PHARMAZIE 309(1):62-69 PISCHEK G; KOCH H THALIDOMIDE ANALOGS .7. METABOLISM AND ELIMINATION IN RAT OF THALIDOMIDE-LIKE COMPOUND K-2004 | 1 | 3 |
| 1164 | 2 | 18 | 625 1976 LANCET 1(7960):635-637 GARDNER E; ORAHILLY R NEURAL CREST, LIMB DEVELOPMENT, AND THALIDOMIDE EMBRYOPATHY | 1 | 14 |
| 1165 | 3 | 14 | 641 1977 ARCHIVES OF TOXICOLOGY 37(2):165-172 JURECKA W; LASSMANN H; STOCKINGER L TERATOLOGIC-NEUROTOXIC EXAMINATION OF BIGLUMIDE (K-2004) AND THALIDOMIDE | 1 | 3 |
| 1166 | 0 | 1 | 656 1977 TERATOLOGY 15(2):A24-A24 THEISEN CT; HABIGER T; SWARTWOOD LD; SCHMIDT HL; WILSON JG THALIDOMIDE DYSMELIA IN RHESUS-MONKEYS - EVIDENCE FOR A PRIMARY EFFECT ON SPINAL GANGLIA | 1 | 3 |
| 1167 | 3 | 7 | 676 1978 LANCET 1(8078):1362-1362 MCBRIDE WG TERATOGENIC ACTION OF THALIDOMIDE | 1 | 1 |
| 1168 | 0 | 0 | 698 1979 HNO 27(9):302-307 WEIDENBECHER M; MAAK G BEHAVIOR OF THE FACIAL-NERVE IN VITAMIN-A AND THALIDOMIDE INDUCED ATRESIA AURIS CONGENITA - MICROSURGICAL AND HISTOLOGICAL ANIMAL STUDY | 1 | 1 |
| 1169 | 2 | 3 | 716 1980 ACTA GENETICAE MEDICAE ET GEMELLOLOGIAE 29(4):295-297 SCHMIDT M; SALZANO FM DISSIMILAR EFFECTS OF THALIDOMIDE IN DIZYGOTIC TWINS | 1 | 8 |
| 1170 | 4 | 12 | 730 1980 MONATSSCHRIFT KINDERHEILKUNDE 128(1):27-29 MILLER A; SCHMIDT CG; HORWITZ A; KOSENOW W COINCIDENCE OF A THALIDOMIDE-INDUCED MALFORMATION AND A LYMPHOMA OF HIGH MALIGNANCY | 1 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1171 | 0 | 0 | 733 1980 TERATOLOGY 21(2):A50-A51 KLEIN NW; PARKER RM; PLENEFISCH JD INVITRO CULTURE OF RAT EMBRYOS ON MONKEY SERUM - EFFECTS OF MENSTRUAL-CYCLE AND THALIDOMIDE CONSUMPTION | 1 | 2 |
| 1172 | 0 | 0 | 743 1981 ARCHIVES OF GYNECOLOGY 232(1-4):611-612 MUHLENSTEDT D; SCHWARZ M GYNECOLOGICAL-ENDOCRINOLOGICAL STUDIES ON THALIDOMIDE-DAMAGED GIRLS | 1 | 1 |
| 1173 | 0 | 0 | 757 1981 LANCET 2(8242):368-368 MCBRIDE WG ANOTHER, LATE THALIDOMIDE ABNORMALITY | 1 | 1 |
| 1174 | 0 | 16 | 783 1982 EUROPEAN JOURNAL OF PEDIATRICS 138(1):77-80 VANREGEMORTER N; HAUMONT D; KIRKPATRICK C; VISEUR P; JEANTY P; DODION J; MILAIRE J; ROOZE M; RODESCH F HOLT ORAM SYNDROME MISTAKEN FOR THALIDOMIDE EMBRYOPATHY - EMBRYOLOGICAL CONSIDERATIONS | 1 | 6 |
| 1175 | 0 | 0 | 811 1983 BRITISH MEDICAL JOURNAL 287(6404):1550-1550 BOWERS PW; POWELL RJ EFFECT OF THALIDOMIDE ON OROGENITAL ULCERATION - REPLY | 1 | 1 |
| 1176 | 6 | 18 | 812 1983 BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE 96(7):910-913 VAISMAN BL; POPOV VP; IGNATEVA TV REDUCTION IN THE TISSUE ASCORBIC-ACID LEVEL IN GUINEA-PIGS BY THALIDOMIDE | 1 | 2 |
| 1177 | 0 | 0 | 817 1983 CLINICAL RESEARCH 31(5):A921-A921 MILLIKAN LE; DOLL NJ; BARNHILL RL; HASTINGS RC; SALVAGGIO JE THE INVITRO EFFECTS OF THALIDOMIDE ON HUMAN POLYMORPHONUCLEAR LEUKOCYTE FUNCTION | 1 | 1 |
| 1178 | 13 | 34 | 818 1983 DEVELOPMENT GROWTH & DIFFERENTIATION 25(4):361-373 MCBRIDE WG; VARDY PH PATHOGENESIS OF THALIDOMIDE TERATOGENESIS IN THE MARMOSET (CALLITHRIX-JACCHUS) - EVIDENCE SUGGESTING A POSSIBLE TROPHIC INFLUENCE OF CHOLINERGIC NERVES IN LIMB MORPHOGENESIS | 1 | 6 |
| 1179 | 1 | 3 | 846 1984 BRITISH JOURNAL OF DERMATOLOGY 111(1):125-126 AYRES S THALIDOMIDE OR VITAMIN-E THERAPY FOR DISCOID LUPUS-ERYTHEMATOSUS | 1 | 2 |
| 1180 | 1 | 2 | 895 1985 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 13(3):509-509 BRODTHAGEN H SIGNIFICANT RESPONSE OF ORAL APHTHOSIS TO THALIDOMIDE TREATMENT | 1 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1181 | 2 | 3 | 896 1985 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 13(3):509-509 GRINSPAN D SIGNIFICANT RESPONSE OF ORAL APHTHOSIS TO THALIDOMIDE TREATMENT - REPLY | 1 | 1 |
| 1182 | 1 | 10 | 897 1985 LANCET 1(8423):288-289 LEHNER T; SULLIVAN FM THALIDOMIDE, OROGENITAL ULCERS, AND THE RISK OF TERATOGENESIS | 1 | 3 |
| 1183 | 5 | 8 | 900 1985 LANCET 2(8450):331-331 CRAWFORD CL THALIDOMIDE AND LEPROSY | 1 | 1 |
| 1184 | 0 | 0 | 926 1986 LEPROSY REVIEW 57(1):76-77 LORETTI A; BARCHI E SUPPLIES OF THALIDOMIDE FOR USE IN LEPROSY | 1 | 1 |
| 1185 | 1 | 1 | 927 1986 LEPROSY REVIEW 57(3):273-273 NEELAMKAVIL P SUPPLIES OF THALIDOMIDE FOR USE IN LEPROSY | 1 | 2 |
| 1186 | 3 | 15 | 930 1986 REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO 28(1):12-14 ARRUDA WO; HACBARTH E; DOI E; SANTAMARIA JR; BARBOSA J; KAJDACSYBALLA AA EFFECT OF THALIDOMIDE ON SERUM LEVELS OF IMMUNOGLOBULINS IGM AND IGA, RHEUMATOID-FACTOR AND ISOHEMAGLUTININS ANTI-A AND ANTI-B IN PATIENTS WITH LEPROMATOUS LEPROSY - A DOUBLE-BLIND-STUDY | 1 | 2 |
| 1187 | 0 | 5 | 954 1988 ANAESTHESIA 43(7):613-614 MCCRORY JW ANESTHESIA AND THALIDOMIDE-RELATED ABNORMALITIES | 1 | 1 |
| 1188 | 4 | 5 | 967 1988 DERMATOLOGICA 176(2):107-107 VIRABEN R; DUPRE A ERYTHEMA-NODOSUM FOLLOWING THALIDOMIDE THERAPY FOR BEHCET DISEASE | 1 | 5 |
| 1189 | 0 | 0 | 979 1988 TERATOLOGY 38(3):201-202 FRASER FC THALIDOMIDE RETROSPECTIVE - WHAT DID WE LEARN | 1 | 4 |
| 1190 | 4 | 6 | 990 1989 BONE MARROW TRANSPLANTATION 4(5):598-598 HEATON DC FAILURE OF THALIDOMIDE TO CONTROL BRONCHIOLITIS OBLITERANS POST BONE-MARROW TRANSPLANT | 1 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1191 | 0 | 0 | 1000 1989 MEDICINA CLINICA 92(15):571-571 CODINA C THALIDOMIDE 1989 | 1 | 1 |
| 1192 | 1 | 2 | 1030 1990 TERATOLOGY 41(2):239-239 MCCREDIE J PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY - COMMENT | 1 | 1 |
| 1193 | 4 | 10 | 1033 1990 TERATOLOGY 41(2):245-246 STEPHENS TD PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY | 1 | 3 |
| 1194 | 0 | 0 | 1049 1991 MEDICINA CLINICA 97(2):79-79 TERCEDOR J; ORTEGO N; RODENAS JM; HERNANDEZ J TREATMENT OF RECURRENT APHTHAE WITH THALIDOMIDE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME | 1 | 1 |
| 1195 | 0 | 0 | 1078 1992 TROPICAL DOCTOR 22(3):139-139 AWOFESO N THALIDOMIDE PERIPHERAL NEUROPATHY | 1 | 4 |
| 1196 | 3 | 4 | 1092 1993 BRITISH MEDICAL JOURNAL 307(6909):939-940 BURROWS NP DIAGNOSIS AND MANAGEMENT OF SYSTEMIC LUPUS-ERYTHEMATOSUS - THALIDOMIDE MODIFIES DISEASE | 1 | 1 |
| 1197 | 0 | 0 | 1096 1993 CLINICAL RESEARCH 41(2):A496-A496 HARLAND CC; STEVENTON GB; MARSDEN JR THALIDOMIDE INDUCED NEUROPATHY AND DRUG METABOLIC POLYMORPHISM | 1 | 1 |
| 1198 | 0 | 0 | 1123 1994 BLOOD 84(10):A431-A431 SCHLEGEL PG; FERNANDEZ LP; BAKER J; CHEN Y; CHAO NJ THALIDOMIDE DOES NOT MODULATE THE IL-2 RESPONSE OF ACTIVATED JURKAT CELLS AS MEASURED BY BETA-GAL-ACTIVITY AND BY IL-2 PRODUCTION | 1 | 1 |
| 1199 | 3 | 30 | 1154 1994 MIKROCHIMICA ACTA 117(1-2):75-85 AUCELIO RQ; CAMPIGLIA AD PHARMACEUTICAL FORMULATION ANALYSIS OF THALIDOMIDE BY SOLID-SURFACE ROOM-TEMPERATURE PHOSPHORIMETRY | 1 | 10 |
| 1200 | 0 | 0 | 1172 1995 ARTHRITIS AND RHEUMATISM 38(6):R10-R10 OLIVER SJ; CHENG TP; BANQUERIGO ML; BRAHN E THALIDOMIDE ANALOGS SUPPRESS RAT COLLAGEN ARTHRITIS | 1 | 2 |
Page 4: 1 2 3 4 5 6 7 8 9
Generated by: HistCite(Vlad).
Version: 2004.09.22